BGMS Bio Green Med Solution, Inc.
Wholesale-Durable Goods, NEC · Nasdaq · SEC CIK 1130166 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY—
TTM net income YoY69.4%
TTM EPS YoY75.3%
Revenue 3-yr CAGR55.1%
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin-156.1%
Net margin-114.5%
FCF margin—
EBITDA margin-155.7%
Returns
ROE-24.2%
ROA-21.3%
ROIC (approx.)-68.7%
Asset turnover0.19x
Leverage & solvency
Liabilities / assets10.9%
Debt / equity0.00x
Current ratio6.84x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.57x
Accruals ratio-9.1%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $0 | $43,000 |
| R&D expense | $848,000 | $6.66M |
| SG&A expense | $7.72M | $5.39M |
| Operating income | -$8.43M | -$12.00M |
| Pretax income | -$2.99M | -$11.99M |
| Income tax | $7,000 | -$782,000 |
| Net income | -$3.00M | -$11.21M |
| EBITDA | -$8.42M | -$12.00M |
| EPS (basic) | -6.45 | -502.46 |
| EPS (diluted) | -6.45 | -502.46 |
| Weighted avg. shares (diluted) | 2.19M | 22,314 |
| Banking | ||
| Net interest income | $62,000 | $12,000 |
| Balance sheet | ||
| Cash & equivalents | $3.50M | $3.14M |
| Receivables | $1.26M | — |
| Inventory | $1.38M | — |
| Current assets | $6.26M | $3.67M |
| PP&E, net | $137,000 | $3,000 |
| Goodwill | $1.57M | — |
| Total assets | $8.19M | $4.09M |
| Current liabilities | $1.33M | $6.27M |
| Total liabilities | $1.34M | $6.27M |
| Shareholders' equity | $6.84M | -$2.17M |
| Shares outstanding | 5.40M | 36,913 |
| Cash flow statement | ||
| Operating cash flow | -$4.77M | -$7.99M |
| Financing cash flow | $5.26M | $7.82M |
| Depreciation & amortization | $5,000 | $6,000 |
| Stock-based compensation | $2.33M | $592,000 |
Free plan shows the latest 2 periods; Pro shows all 28 🔒
· This company does not report gross profit in XBRL.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.